Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Paradigm Biopharmaceuticals Ltd. has announced the cancellation of a total of 581,570 securities as a result of an employee share scheme buy-back on April 26, 2024. The announcement affects both ordinary fully paid and restricted securities, marking a significant change in the company’s issued capital structure.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
